PCOS hormone tracking in 2026 requires knowing exactly what to ask for, when to test, and how to read results in context. Getting a useful hormone panel for PCOS means going beyond the standard blood draw. Most standard blood panels ordered at a first appointment miss several of the most clinically relevant markers, and many results are reported as normal when they are suboptimal for someone with PCOS symptoms. Reddit's PCOS communities have spent years sharing what panels finally produced actionable information and what timing errors produced misleading results.
"My GP said my hormones were normal but I had every PCOS symptom"
This is one of the most repeated frustrations in r/PCOS. A standard blood panel comes back within reference range, a clinician concludes there is no hormonal issue, and the patient is left with a full symptom picture and no diagnosis or pathway forward.
The community has identified several consistent reasons this happens. First, standard panels often test total testosterone rather than free testosterone, which is the biologically active fraction and the one most relevant to androgenic symptoms like acne, hair loss, and hirsutism. Free testosterone can be elevated while total testosterone sits within the normal range.
Second, insulin resistance, which is present in a significant proportion of PCOS cases and is often the primary driver of symptoms, is rarely tested on a standard panel. Fasting insulin alongside fasting glucose gives an insulin-to-glucose ratio that is far more informative than glucose alone, but it is not standard practice in many primary care settings.
Third, panels are frequently timed incorrectly. Testing LH and FSH on the wrong cycle day produces results that appear normal when they are not, or that flag as abnormal when the timing explains the reading rather than a pathology.
What research says about PCOS hormone tracking and testing
PCOS is diagnosed using the Rotterdam criteria, which require two of three features: irregular or absent ovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound. Hormone testing is primarily used to establish biochemical hyperandrogenism and to rule out other conditions that mimic PCOS, including thyroid dysfunction, hyperprolactinaemia, and congenital adrenal hyperplasia.
Research on hormone testing in PCOS identifies several markers with the strongest diagnostic and management relevance. Free androgen index or free testosterone is more sensitive for hyperandrogenism than total testosterone alone. DHEA-S distinguishes adrenal androgen excess from ovarian androgen excess and has implications for treatment pathway. AMH is elevated in most PCOS cases and correlates with ovarian reserve and follicle count. Fasting insulin and HOMA-IR quantify insulin resistance which affects treatment decisions significantly.
LH to FSH ratio is elevated in many PCOS cases, often above 2:1, but this ratio is only meaningful when tested in the early follicular phase, typically cycle days 2 to 5. Testing outside this window produces results that cannot be meaningfully interpreted in the PCOS context.